Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported... Oncol Ther (2018) 6:189–201 https://doi.org/10.1007/s40487-018-0065-7 ORIGINAL RESEARCH Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) . . . . . Tian Qi Wang Joseph N. Samuel M. Catherine Brown Ashlee Vennettilli Hannah Solomon . . . . . . Lawson Eng Mindy Liang Gursharan Gill Zahra Merali Chenchen Tian Nicholas Y. H. Cheng . . . . Matthew Campbell Devalben Patel Ai Xin Liu Geoffrey Liu Doris Howell Received: May 9, 2018 / Published online: October 22, 2018 The Author(s) 2018 chemotherapy, captured chemotoxicities and ABSTRACT respective severities. Patient telephone surveys assessed whether healthcare providers had Introduction: Systematic documentation of addressed chemotoxicities to the patients’ chemotoxicities in outpatient clinics is chal- satisfaction. lenging. Incorporating patient-reported out- Results: Over a broad demographic of 497 come (PRO) measures in clinical workflows can patients receiving chemotherapy, 90% (95% CI be an efficient strategy to strengthen the 84–96%) with significant chemotoxicities assessment of symptomatic treatment toxicities (n = 107) reported that their providers had dis- in oncology clinical practice. We compared the cussed toxicities with them; of these, 70% adequateness, feasibility, and acceptability of received a therapy management change, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Loading next page...
 
/lp/springer-journals/routine-surveillance-of-chemotherapy-toxicities-in-cancer-patients-WlVacikpgU
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-018-0065-7
Publisher site
See Article on Publisher Site

Abstract

Oncol Ther (2018) 6:189–201 https://doi.org/10.1007/s40487-018-0065-7 ORIGINAL RESEARCH Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) . . . . . Tian Qi Wang Joseph N. Samuel M. Catherine Brown Ashlee Vennettilli Hannah Solomon . . . . . . Lawson Eng Mindy Liang Gursharan Gill Zahra Merali Chenchen Tian Nicholas Y. H. Cheng . . . . Matthew Campbell Devalben Patel Ai Xin Liu Geoffrey Liu Doris Howell Received: May 9, 2018 / Published online: October 22, 2018 The Author(s) 2018 chemotherapy, captured chemotoxicities and ABSTRACT respective severities. Patient telephone surveys assessed whether healthcare providers had Introduction: Systematic documentation of addressed chemotoxicities to the patients’ chemotoxicities in outpatient clinics is chal- satisfaction. lenging. Incorporating patient-reported out- Results: Over a broad demographic of 497 come (PRO) measures in clinical workflows can patients receiving chemotherapy, 90% (95% CI be an efficient strategy to strengthen the 84–96%) with significant chemotoxicities assessment of symptomatic treatment toxicities (n = 107) reported that their providers had dis- in oncology clinical practice. We compared the cussed toxicities with them; of these, 70% adequateness, feasibility, and acceptability of received a therapy management change,

Journal

Oncology and TherapySpringer Journals

Published: Oct 22, 2018

References